Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
P
376180
vs
K
KOSPI 200
Over the past 12 months, Picogram Co Ltd has underperformed KOSPI 200, delivering a return of -51% compared to KOSPI 200's +116% growth.
Stocks Performance
376180 vs KOSPI 200
Performance Gap
376180 vs KOSPI 200
Performance By Year
376180 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Picogram Co Ltd
Glance View
Picogram Co Ltd makes in vitro diagnostic products and related testing materials used in labs and medical settings. Its business centers on test kits, reagents, and other consumables that help detect disease markers and support clinical testing. The company sells these products to hospitals, laboratories, and diagnostic distributors that need reliable tools for routine and specialized testing. Picogram earns money mainly by selling its diagnostic products and related supplies, rather than by charging for software or one-time equipment installations. That means its revenue is tied to how often customers reorder test materials and how widely its tests are adopted in clinical workflows. In this kind of business, the key value is in the accuracy, consistency, and ease of use of the assay itself. What makes Picogram's role different is that it sits in the medical testing supply chain as a maker of consumable diagnostic tools. It does not treat patients directly; instead, it supplies the materials that doctors, labs, and other healthcare buyers use to make test results possible. That gives it a business model built around recurring product demand and technical trust.